Company Overview - Biogen Inc. (BIIB) is a profit-generating company that has experienced significant declines in earnings and share price over recent years, primarily due to decreasing revenue from its legacy Multiple Sclerosis treatments [1]. Investment Insights - The article emphasizes the importance of patient investing through both good and bad times, highlighting that wealth is created through the slow accumulation of high-quality assets [1]. - It suggests that mixing a steady investment approach with high-risk/high-reward opportunities and transformative technologies can enhance the investment experience [1].